Core Insights - Reviva Pharmaceuticals is advancing its brilaroxazine program for schizophrenia, with plans for a second Phase 3 trial (RECOVER-2) to gather additional efficacy and safety data before submitting a New Drug Application (NDA) [1][2] Clinical Development and Regulatory - The FDA has provided clear guidance, recommending a second Phase 3 trial to enhance the data package for brilaroxazine [2][3] - Brilaroxazine has shown broad-spectrum efficacy in major symptom domains of schizophrenia, including negative symptoms and anxiety/depression, with a well-tolerated safety profile observed in over 900 subjects [3] - The Phase 3 RECOVER open-label extension study demonstrated robust efficacy sustained over one year, with significant improvements in PANSS total score and other clinical measures [3] - Only less than 1% of patients reported symptom relapse during the one-year treatment period, and no clinically meaningful changes in movement disorder scales were observed [3][7] Financial Results - For the fiscal year ended December 31, 2025, the company reported a net loss of approximately $19.9 million, or $5.48 per share, an improvement from a net loss of approximately $29.9 million, or $17.73 per share, in 2024 [6][16] - The company’s cash and cash equivalents increased to approximately $14.4 million as of December 31, 2025, compared to $13.5 million in 2024 [8][14] Financing - Reviva completed several public equity offerings, raising gross proceeds of $10.0 million in March 2026, $9.0 million in September 2025, and $10.0 million in June 2025 [7] - The company plans to use the net proceeds from the March 2026 offering to fund the RECOVER-2 Phase 3 trial and for general corporate purposes [7] Anticipated Milestones and Events - The RECOVER-2 trial is expected to initiate in mid-2026, with trial-related activities starting in Q2-2026 and patient enrollment planned for Q3-2026 [7] - Additional publications on brilaroxazine for schizophrenia treatment are anticipated in 2026 [7]

Fleet Modernization - DHT Holdings, Inc. has taken delivery of the DHT Gazelle, a VLCC newbuilding from Hyundai Samho Heavy Industries, marking the third of four deliveries scheduled for the first half of 2026 [1] - The DHT Gazelle will commence a five- to seven-year time charter contract with a major oil company, enhancing the company's revenue potential [1] - The final newbuilding in the Antilope-class is expected in June 2026, aligning with the scheduled mid-year delivery of the DHT Bauhinia, which was built in 2007 [2] Financial and Operational Strategy - The fully funded state-of-the-art newbuildings are expected to enhance the company's earnings power, fleet efficiency, and service offerings [2] - DHT operates an integrated management structure across multiple locations, including Monaco, Norway, Singapore, and India, focusing on quality operations and customer service [3] - The company maintains a prudent capital structure that supports stability through business cycles, with a disciplined capital allocation strategy that includes cash dividends, vessel investments, debt prepayments, and share buybacks [3]

Core Viewpoint - iQIYI, Inc. is advancing its corporate strategy through a proposed listing on the Hong Kong Stock Exchange, a share repurchase program, and the launch of its proprietary AI agents, Nadou Pro, aimed at enhancing its market position and shareholder value [1][2][5]. Proposed Listing - iQIYI has submitted a confidential application for a proposed listing of its Class A ordinary shares on the Hong Kong Stock Exchange, aiming to improve access to capital markets and broaden its investor base [2]. - The proposed listing is contingent upon approvals from the HKEX and the China Securities Regulatory Commission, with no guarantee on the timing or occurrence of the listing [3]. Share Repurchase Program - The board of directors has approved a share repurchase program allowing the company to buy back up to US$100 million of its shares over the next 18 months, effective immediately [5]. - Repurchases may occur through various means, including open market transactions and block trades, depending on market conditions [6]. Launch of Proprietary AI Agents Nadou Pro - iQIYI has initiated open commercial testing for Nadou Pro, its proprietary AI agents designed for professional long-form video generation, integrating advanced foundation models with the company's expertise in content production [7].

Core Insights - Auddia Inc. announced the publication of a whitepaper by LT350, detailing a modular canopy architecture that converts parking lots into power-sovereign AI inference nodes [1][3][4] Company Overview - LT350 is one of three new businesses that will merge with Auddia under the McCarthy Finney holding company if the business combination with Thramann Holdings is completed [2] - LT350 holds 13 issued and 3 pending patents for a solar parking lot canopy infrastructure that integrates modular battery storage and GPU cartridges [12] Industry Context - The global datacenter ecosystem is facing challenges such as power availability, land scarcity, and grid interconnection delays, which traditional datacenter development cannot address [3] - The shift from centralized AI training to real-time inference necessitates compute resources to be located near data generation sites like hospitals and financial institutions [4] Technological Innovation - LT350's architecture allows for rapid deployment of AI inference nodes, potentially within weeks or months, bypassing traditional land acquisition and zoning issues [5] - The platform features a hybrid solar-plus-storage model that enhances power sovereignty, providing predictable costs and resilience against curtailment [6] Deployment Advantages - LT350's canopies can be installed close to high-value environments, enabling features such as modular GPU cartridges, optimized memory cartridges, and local fiber backhaul for high-bandwidth connectivity [7][8] - The architecture supports deterministic low latency and simplifies compliance for regulated workloads, which are increasingly required for real-time inference [9] Future Outlook - The whitepaper outlines LT350's memory-augmented architecture designed for next-generation inference workloads, including long-context models and high-bandwidth data flows from autonomous vehicles [10]

Core Insights - CBAK Energy Technology, Inc. reported significant financial growth in 2025, with a 131.8% increase in fourth-quarter net revenues year-over-year, reaching $58.80 million, driven by strong demand for new battery models and raw materials [4][6][12] Financial Performance - Fourth Quarter 2025 net revenues from Light Electric Vehicles (LEV) surged by 524.1% year-over-year to $12.92 million, validating the company's successful international market penetration [4][7] - The Battery Raw Materials Segment (Hitrans) experienced unprecedented growth of 944.1% year-over-year, reaching $27.98 million, reflecting a rebound in raw material pricing [4][8] - Full Year 2025 consolidated net revenues reached $195.19 million, an 11% increase from $176.61 million in 2024, primarily driven by the battery raw materials segment and LEV battery sales [4][13] Operational Developments - The company successfully launched a new production line for the Model 40135 at its Dalian facility, adding 2.3 GWh of capacity, and two new production lines for the Model 32140 at the Nanjing facility, contributing an additional 3.0 GWh [4][5] - The transition from legacy battery models to next-generation products is expected to enhance revenue and profitability as customer demand continues to grow [3][5] Cost and Margin Analysis - Gross profit for the fourth quarter of 2025 was $4.28 million, with a gross margin of 7.3%, down from 13.1% in the previous year, primarily due to higher unit costs during the ramp-up phase of new production lines [9][15] - Research and development expenses increased to $5.30 million in Q4 2025, reflecting the company's commitment to advancing its product offerings [10][16] Strategic Initiatives - The establishment of a Malaysian manufacturing subsidiary in April 2025 is part of the company's strategy to mitigate the impact of the PRC's export tax rebate policy phase-out for lithium-ion batteries [3][5] - The company anticipates a significant operational turnaround as it completes capacity ramp-ups and continues to meet the growing demand for its new battery cells [5][12]

Core Points - Air Canada expresses condolences for the tragic accident involving Flight AC8646, which occurred on March 22, 2026, at New York LaGuardia Airport [2][3] - The company is preparing for its 2026 annual meeting of shareholders, where it will discuss achievements and address shareholder concerns [2] Meeting Details - The annual meeting is scheduled for May 1, 2026, at 8:30 a.m. PT (11:30 a.m. ET) in a hybrid format, allowing both in-person and virtual attendance [7] - Shareholders are encouraged to vote in advance using various methods, with a deadline of noon (ET) on April 29, 2026 [8] Governance and Compensation - The circular includes information on the election of directors, appointment of auditors, and an advisory vote on executive compensation, among other matters [4] - Air Canada reviews its governance practices, including board renewal and CEO succession, and provides details on executive compensation based on fiscal 2025 performance [5] Shareholder Engagement - The company will make a $1 charitable donation to the Air Canada Foundation for every shareholder account that votes at the meeting, regardless of the vote outcome [9] - Shareholders can access meeting materials online and request paper copies if needed [12] Company Overview - Air Canada is the largest airline in Canada and a founding member of Star Alliance, providing scheduled service to over 180 airports globally [13] - The airline aims for net-zero greenhouse gas emissions by 2050 as part of its climate-related ambitions [13]

Core Insights - The U.S. FDA has granted Fast Track designation to ZW191, an antibody-drug conjugate targeting folate receptor-α (FRα), for treating advanced or metastatic platinum-resistant ovarian cancer [1][4] - ZW191 is designed to target FRα, which is expressed in approximately 75% of high-grade serous ovarian carcinomas, over 50% of endometrial cancers, and around 70% of lung adenocarcinomas [2] - The Fast Track designation aims to expedite the development and review timelines for drugs that address serious conditions, facilitating quicker access to therapeutics for patients [3] Company Overview - Zymeworks Inc. is a biotechnology company focused on managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel biotherapeutics aimed at improving care for difficult-to-treat diseases, including cancer [5] - The company is advancing a robust pipeline of product candidates, leveraging expertise in antibody-drug conjugates and multispecific antibody therapeutics targeting significant unmet medical needs [5] - Zymeworks has developed Ziihera, a HER2-targeted bispecific antibody, and has entered into agreements with BeOne Medicines Ltd. and Jazz Pharmaceuticals for the development and commercialization of zanidatamab in various territories [5]

Core Insights - RCI Banque has released its audited consolidated financial statements for the year ending December 31, 2025, which are now accessible on the Mobilize Financial Services website [1] Group 1 - The financial statements provide a comprehensive overview of RCI Banque's financial performance and position as of the end of 2025 [1] - The availability of these statements on the Mobilize Financial Services website indicates a commitment to transparency and accessibility for stakeholders [1]

Core Insights - The 2026 Yangzhou Half Marathon and the 4th East Asian Half Marathon Championships featured 23,000 runners, showcasing the event's popularity and significance in the region [1] - Elite athletes from 35 countries participated, with Kenya's Alex NZIOKA MATATA and Miriam CHEBET setting new course records, enhancing the event's international reputation [2] - This year marks the 20th anniversary of the Yangzhou Marathon and its first event since receiving the World Athletics' "Platinum Label" status, indicating its adherence to the highest international standards [3] Event Highlights - The marathon took place during Yangzhou's "misty March," allowing participants to experience the city's cultural heritage while racing past historical landmarks [4] - The event utilized AI-powered robotic assistants to ensure efficient race operations, reflecting advancements in event management technology [3] - The course design not only emphasizes competition but also promotes cultural appreciation, as runners traverse significant sites like the Dongguan Ancient Ferry and Slender West Lake [4]

Core Viewpoint - The 2026 JD.com Suqian Marathon successfully took place, showcasing Suqian's growth and cultural vibrancy as it celebrates its 30th anniversary as a prefecture-level city [1][2]. Group 1: Event Overview - The marathon attracted 12,000 runners from both domestic and international locations, highlighting the event's significance and appeal [1]. - The race route of 42.195 kilometers was designed to reflect Suqian's beautiful spring scenery and the city's development over the past three decades [2]. Group 2: Cultural and Community Engagement - A large-scale painting project titled "Painting Suqian in Danqing" featured a 300-meter giant scroll created by painting enthusiasts, illustrating Suqian's urban changes and cultural appeal [2]. - The event included 60 music cheering stations and themed performance zones, featuring various artistic forms such as pop bands and traditional folk music, enhancing the festive atmosphere of the marathon [2].